The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
- Conditions
- HIV InfectionsMycobacterium Avium-intracellular Infection
- Registration Number
- NCT00002336
- Lead Sponsor
- Abbott
- Brief Summary
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (22)
Univ of Arizona / Health Science Ctr
🇺🇸Tucson, Arizona, United States
California Med Research Group
🇺🇸Fresno, California, United States
HIV Research Group
🇺🇸San Diego, California, United States
Saint Francis Mem Hosp
🇺🇸San Francisco, California, United States
Kaiser Permanente Med Ctr
🇺🇸San Francisco, California, United States
Santa Clara Valley Med Ctr
🇺🇸San Jose, California, United States
TheraFirst Med Ctrs Inc
🇺🇸Fort Lauderdale, Florida, United States
Dr Nelson Zide
🇺🇸Hollywood, Florida, United States
Infectious Disease Research Institute Inc
🇺🇸Tampa, Florida, United States
Indiana Univ Hosp
🇺🇸Indianapolis, Indiana, United States
Scroll for more (12 remaining)Univ of Arizona / Health Science Ctr🇺🇸Tucson, Arizona, United States